Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6

Journal of Magnetic Resonance Imaging

Volumn 13, Issue 4, 2001, Pages 553-559

  Boesch, S M ^a   Schocke, M ^a   Burk K ^a   Hollosi, P ^a,b   Fornai, F ^a   Aichner, F T ^c   Poewe, W ^a   Felber, S ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

ADCA I; Ataxia; Proton magnetic resonance spectroscopy; SCA2; SCA6

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN METABOLISM; BRAIN SLICE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; RELAXATION TIME; SPINOCEREBELLAR DEGENERATION;

ADULT; ASPARTIC ACID; CHOLINE; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUTATION; PROTONS; SPINOCEREBELLAR ATAXIAS; STATISTICS, NONPARAMETRIC;

EID: 0035081926     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1078     Document Type: Article

References (40)

1. The prevalence and occurrence of some rare neurological diseases in Iceland
2. The clinical features and classification of the late autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of "the Drew family of Walworth"
3. Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1
4. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel
5. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats
6. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2
7. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT
8. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
9. Proton magnetic resonance spectroscopy: Clinical applications in children with nervous system diseases
10. Confirmation of the SCA-2 locus as an alternative locus for dominantly inherited spinocerebellar ataxias and refinement of the candidate region
11. Idiopathic cerebellar ataxia of late onset: Natural history and MRI morphology
12. Proton magnetic spectroscopic imaging in patients with cerebellar degeneration
13. Spinocerebellar ataxia 2 (SCA2): Morphometric analyses in 11 autopsies
14. Spinocerebellar ataxia type 6: Gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset
15. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy
16. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1
17. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio
18. Central nervous system trans-synaptic effects of acute axonal injury: A 1H magnetic resonance spectroscopy study
19. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy
20. Alzheimer disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy
21. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy
22. MRS to differentiate multiple system atrophy from idiopathic Parkinson's disease
23. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
24. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations
25. Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities
26. Magnetic resonance evaluation of stroke
27. Proton NMR spectroscopy of Canavan's disease
28. Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1
29. What the clinician can learn from MRS lactate measurements
30. Mitochondrial disorders: Analysis of their clinical and imaging characteristics
31. Magnetic resonance spectroscopy (MRS) in five patients with treated propionic acidemia
32. Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes
33. Combined magnetic resonance imaging and proton resonance spectroscopy of patients with acute stroke
34. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease
35. Clinical correlation of striatal 1H MRS changes in Huntington's disease
36. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases
37. Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: A proton magnetic resonance spectroscopy study
38. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
39. Pattern of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy